Chandan Healthcare Ltd. shows potential with a high ROE and low debt, but lacks revenue growth and profitability compared to its peers. Companies like Max Healthcare and Apollo Hospitals are strong performers, but others like Fortis and Aster DM are overvalued with weak fundamentals. Overall, a cautious approach is recommended for investors considering this sector.

• • Chandan Healthcare has a high ROE (47.83) but lacks revenue growth and positive earnings metrics.
• • Max Healthcare leads in revenue growth and profitability, while Aster DM is undervalued but financially weak.
• • Fortis Healthcare is significantly overvalued with poor margins.